PrEP

Study confirms no transmissions with undetectable HIV

By

The largest treatment-as-prevention study for gay and bisexual men confirms that people on antiretroviral therapy with undetectable viral load do not transmit HIV. Results from the PARTNER2 study, which enrolled nearly 1,000 mixed-status gay male couples in 14 European countries, saw no genetically linked HIV transmissions when the positive partner was on effective treatment. “PARTNER2 […]

Study confirms no transmissions with undetectable HIV Read More »

One year of preventing new HIV infections throughout B.C.

By

Thousands of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on Jan. 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see

One year of preventing new HIV infections throughout B.C. Read More »

One year of preventing new HIV infections throughout B.C.

By

THOUSANDS of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on January 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see

One year of preventing new HIV infections throughout B.C. Read More »

High levels of unmet PrEP needs among transgender women in Brazil

By

A study recently published in The Journal of Acquired Immune Deficiency Syndromes indicates that transgender (trans) women in Brazil had low levels of pre-exposure prophylaxis (PrEP) awareness. This was combined with significant proportions being willing to use PrEP as a prevention tool and being eligible for PrEP. Another recent qualitative study published in Culture, Health

High levels of unmet PrEP needs among transgender women in Brazil Read More »

PrEP can ‘significantly’ reduce HIV rates across populations, study says

By

(CNN) – HIV pre-exposure prophylaxis or PrEP, the use of drugs to prevent HIV infection, among men who have sex with men can significantly reduce new infections across an entire population of men, a new study finds. Based on introduction of the intervention, HIV infections diagnosed in men who have sex with men in the

PrEP can ‘significantly’ reduce HIV rates across populations, study says Read More »

What you need to know about provinces covering costs for an HIV prevention drug

By

Alberta recently joined 6 other provinces in covering some or all of the costs for an HIV prevention drug program. It’s known as Pre-Exposure Prophylaxis or PrEP. Dr. Julio Montaner, head of the BC Centre for Excellence in HIV/AIDS, speaks with Global National about why some provincial governments are picking up the costs-and who is

What you need to know about provinces covering costs for an HIV prevention drug Read More »

PrEP: What you need to know about provinces covering costs for an HIV prevention drug

By

Alberta recently joined 6 other provinces in covering some or all of the costs for an HIV prevention drug program. It’s known as Pre-Exposure Prophylaxis or PrEP. Dr. Julio Montaner, head of the BC Centre for Excellence in HIV/AIDS, speaks with Global News about why some provincial governments are picking up the costs-and who is

PrEP: What you need to know about provinces covering costs for an HIV prevention drug Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search